Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stefansson

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pathology|September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survivalTor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancerJone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
BMC Cancer|May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
British Journal of Cancer|May 14, 2008
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinomaI B Engelsen, M Mannelqvist, I M Stefansson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2015
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomasSigmund Ytre-Hauge, Jenny A Husby, Inger J Magnussen, et al.
British Journal of Cancer|February 24, 2011
High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancerK K Mauland, J Trovik, E Wik, et al.
Oncotarget|October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responsesGeir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Brain : a Journal of Neurology|December 5, 2006
The genetic spectrum of a population-based sample of familial hemiplegic migraineL L Thomsen, M Kirchmann, A Bjornsson, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
British Journal of Cancer|March 15, 2012
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeC Krakstad, J Trovik, E Wik, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pathology|September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survivalTor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancerJone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
BMC Cancer|May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
British Journal of Cancer|May 14, 2008
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinomaI B Engelsen, M Mannelqvist, I M Stefansson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2015
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomasSigmund Ytre-Hauge, Jenny A Husby, Inger J Magnussen, et al.
British Journal of Cancer|February 24, 2011
High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancerK K Mauland, J Trovik, E Wik, et al.
Oncotarget|October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responsesGeir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Brain : a Journal of Neurology|December 5, 2006
The genetic spectrum of a population-based sample of familial hemiplegic migraineL L Thomsen, M Kirchmann, A Bjornsson, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
British Journal of Cancer|March 15, 2012
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeC Krakstad, J Trovik, E Wik, et al.
Pageof 7